Original article
Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study
Comparación de las características clínicas basales entre personas con diabetes tipo 2 en terapia de segunda línea previamente agregada con dapagliflozina u otro fármaco hipoglucemiante oral. Estudio AGORA
Vicente Pallarés-Carrataláa,1,
, Antonio Ruiz-Garcíab,c,1, Adalberto Serrano-Cumplidod, Antonio Segura Fragosoe, Verónica Fernández-Pascualf, Beatriz Sánchez-Sánchezf, María Inmaculada Cervera-Pérezg, Francisco Javier Alonso-Morenoh, Ezequiel Arranz-Martínezi, Alfonso Barquilla-Garcíaj, Daniel Rey-Aldanak, José Polo Garcíal, Sergio Cinza-Sanjurjom,n, on behalf of the Investigators of the AGORA study, of the Spanish Society of Primary Care Physicians SEMERGEN Foundation
Corresponding author
a Department of Medicine, Jaume I University, Castellon, Spain
b Specialist in Family and Community Medicine, Pinto University Health Center, Lipids and Cardiovascular Prevention Unit, Pinto, Madrid, Spain
c Department of Medicine, European University of Madrid, Villaviciosa de Odón, Madrid, Spain
d Specialist in Family and Community Medicine, Getxo, Vizcaya, Spain
e Epidemiology Unit, Semergen Research Agency, Madrid, Spain
f Investigation Unit, SEMERGEN Foundation, Madrid, Spain
g Specialist in Family and Community Medicine, Tendetes Health Center, Valencia, Spain
h Specialist in Family and Community Medicine, Sillería Health Center, Toledo, Spain
i Especialista en Medicina Familiar y Comunitaria, San Blas Health Center, Parla, Madrid, Spain
j Specialist in Family and Community Medicine, Trujillo Health Center, Cáceres, Spain
k Specialist in Family and Community Medicine, A Estrada Health Center, Pontevedra, Spain
l Specialist in Family and Community Medicine, Casar de Cáceres Health Center, Cáceres, Spain
m Milladoiro Health Centre, Health Area of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), A Coruña, Spain
n Networking Biomedical Research, Centre-Cardiovascular Diseases (CIBERCV), Santiago de Compostela, Spain
Ver másRead
1500
Timeswas read the article
351
Total PDF
1149
Total HTML
Article information
ISSN: 25299123Original language: English
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2026 10 | 34 | 7 | 41 |
| 2026 9 | 161 | 49 | 210 |
| 2026 8 | 72 | 43 | 115 |
| 2026 7 | 139 | 47 | 186 |
| 2026 6 | 31 | 26 | 57 |
| 2026 5 | 74 | 27 | 101 |
| 2026 4 | 66 | 23 | 89 |
| 2026 3 | 106 | 41 | 147 |
| 2026 2 | 140 | 55 | 195 |
| 2026 1 | 210 | 31 | 241 |
| 2025 12 | 58 | 0 | 58 |
| 2025 11 | 1 | 2 | 3 |
| 2025 10 | 3 | 0 | 3 |
| 2025 9 | 4 | 0 | 4 |
| 2025 8 | 6 | 0 | 6 |
| 2025 7 | 10 | 0 | 10 |
| 2025 6 | 2 | 0 | 2 |
| 2025 5 | 7 | 0 | 7 |
| 2025 4 | 9 | 0 | 9 |
| 2025 3 | 12 | 0 | 12 |
| 2025 2 | 4 | 0 | 4 |
Show all
